Bayesian Capital Management’s Science 37 Holdings, Inc. Common Stock SNCE Stock Holding History

Bayesian Capital Management’s Portfolio SNCE Stock Details SNCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,624	Closed	-$65K	–	1081
2022 Q2	$65K	Buy	+1,624	New	+$119K	0.01%	709

Other funds holding SNCE

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

GCM

Glynn Capital Management Menlo Park, California $209M AUM 31.14% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

MCMU

MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Bayesian Capital Management's SNCE Position: Q3 2022 in Review

Bayesian Capital Management sold out of Science 37 Holdings, Inc. Common Stock (SNCE) in Q3 2022, closing a stake of 1,624 shares — an estimated $65K sold.

Bayesian Capital Management first reported a position in SNCE in Q2 2022 and held it in 1 quarter. The position peaked at $65K in Q2 2022. 68 funds tracked by Wall St. Rank hold SNCE as of Q3 2022.

Bayesian Capital Management reported no remaining Science 37 Holdings, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Bayesian Capital Management sold 1,624 Science 37 Holdings, Inc. Common Stock shares in Q3 2022, an estimated $65K.
Bayesian Capital Management first reported a position in Science 37 Holdings, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
Bayesian Capital Management's Science 37 Holdings, Inc. Common Stock position peaked at $65K in Q2 2022.
68 funds tracked by Wall St. Rank held Science 37 Holdings, Inc. Common Stock as of Q3 2022.

Based on Bayesian Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.